![]() |
市場調查報告書
商品編碼
2125321
藥品泡殼包裝:市佔率分析、產業趨勢與統計、成長預測(2026-2031)Pharmaceutical Blister Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
根據 Mordor Intelligence 估計,到 2026 年,藥品泡殼包裝市值將達到 249.7 億美元,從 2025 年的 233.1 億美元成長到 2031 年的 351.7 億美元。
預計 2026 年至 2031 年的複合年成長率為 7.10%。

本報告按材料(塑膠、紙/紙板、鋁箔)、技術(冷成型、熱封/熱收縮、熱成型)、應用(片劑、膠囊等)、最終用戶(品牌藥/學名藥生產商等)和地區(北美、歐洲、亞太地區、中東和非洲、南美)進行分類。
監管機構認為單劑量包裝是減少用藥錯誤的有效方法,美國食品藥物管理局(FDA)提案的一項規則草案要求市售的口溶錠和口崩膜必須以單劑量包裝運輸。醫院和零售藥劑師也證實,可視化的劑量指引可以減少老年病患漏服藥物的情況。保險公司歡迎降低再入院風險,因為這是他們提供報銷獎勵的依據。為此,合約包裝公司正在增加多產品泡殼包裝生產線,這種包裝可以將一天的劑量集中在一個泡殼卡上。雖然這種趨勢在北美最為顯著,但隨著用藥依從性數據被整合到電子處方箋平台中,類似的趨勢也正在歐洲出現。
歐盟的《包裝和包裝廢棄物法規》規定,2030年後投放市場的所有醫療包裝都必須設計成可回收的。 TekniPlex等供應商現在提供中等阻隔性的吸塑薄膜,其中含有30%的消費後回收樹脂,且不影響其防潮性能。北歐化工的「Bornewables」等級產品採用可再生原料製造,為尋求減少碳足跡的製造商提供了可控來源的聚合物選擇。一家日本加工商實施了閉合迴路系統,用於收集廢鋁箔並將其重熔成顆粒,與使用原生材料相比,可減少約20%的二氧化碳排放。
鋁箔是吸塑包裝的標準阻隔材料,但由於地緣政治關稅和中國出口政策的變化,其價格正面臨上漲。歐洲鋁箔生產商報告稱,2024年前九個月的產量將達到約72.4萬噸,但由於能源價格飆升,供應仍然緊張。樹脂生產商也將石腦油成本的上漲轉嫁到PVC和PET樹脂的價格上。品牌商正在將採購來源多元化,轉向東南亞和拉丁美洲,同時也測試聚丙烯複合材料,這種材料可以在不影響阻隔性能的前提下減少鋁箔的厚度。
塑膠藥品泡殼包裝市場由成熟的PVC-PVDC價值鍊和成熟的熱成型性能所驅動。市場規模與大規模生產的學名藥密切相關,低成型溫度和可預測的密封強度是關鍵。然而,隨著品牌所有者要求包裝材料可回收(作為生活垃圾)並減少範圍3排放,紙基包裝結構正逐漸獲得市場認可。覆有薄聚合物或鋁層的紙板複合材料的保存期限已接近9個月,其應用範圍也從維生素擴展到處方箋消化器官系統藥物。
由於深拉伸型腔能夠保護對水分敏感的化合物,因此對鋁箔和塑膠冷成型鋁箔的需求仍然強勁。然而,隨著加工商採用奈米層塗層以較少的金屬即可達到類似的阻隔性能,鋁箔厚度正呈下降趨勢。 Ecobliss 的冷封卡片表明,黏合劑無需加熱工藝,從而降低了包裝車間的能耗。 TekniPlex 的吸塑包裝膜含有 30% 的 PCR(再生塑膠),在維持藥劑師目視檢查所需的透明度的同時,也為樹脂的循環利用指明了方向。
到2025年,熱成型製程將佔據藥品泡殼包裝市場72.45%的佔有率。這主要得益於其生產線速度快,且透明腔體便於目視檢查。成型-填充-封口(FFS)生產線以每分鐘600包的速度持續生產,以滿足重磅藥物片劑的生產需求。然而,由於活性成分(API)對水分敏感,製造商正被迫轉向冷成型工藝,因為鋁箔在冷成型過程中幾乎不透水蒸氣。儘管材料成本不斷上漲,但隨著特學名藥和孤兒藥產量的成長,冷成型生產線的藥品泡殼包裝市場規模仍在擴大。
目前,冷泡設備的供應商正在整合伺服驅動分度器,這提高了鋁箔的使用效率,並減少了高達15%的廢料。 Aptar CSP Technologies公司已擴大其活性泡殼包裝在歐洲的生產規模,以滿足該地區對整合式乾燥劑通道的需求,該通道無需使用額外的乾燥劑袋即可防止水解。連續生產的倡導者正在推廣「粉末到包裝」的一體化生產線,在該生產線上,片劑可在幾分鐘內完成壓片、稱重和泡殼密封工序,從而最大限度地減少等待時間檢驗。
預計到2025年,亞太地區將成為全球最大的市場,佔全球銷售額的33.97%,並預計到2031年將以8.87%的複合年成長率成長。印度、中國和新加坡政府正在為自動化包裝生產線提供稅額扣抵,而當地的合約研發生產機構(CDMO)正在為歐洲的學名藥爭取供應合約。在東京國際藥品包裝展(Interphex Tokyo)上,日本供應商重點介紹了數位化工具如何降低缺陷率,並著重介紹了透明阻隔膜和人工智慧檢測技術。與PIC/S GMP的區域協調正在加速跨境分銷,使跨國公司能夠在多個東協市場檢驗單一包裝。
北美憑藉其高價值的生物製藥產品線和對智慧黏合包裝的早期應用,佔據第二大市場佔有率。美國也受益於製造業回流,縮短了供應鏈並避免了地緣政治風險。隨著鋁關稅的重新實施,加工商正透過確保國內鋁箔軋延產能或改用聚合物基蓋材料來降低進口價格波動的風險。加拿大工廠正在採用再生能源,從而能夠宣傳其「碳中和」包裝,並獲得了公共保險公司的支持。歐洲憑藉嚴格的品質標準和對永續材料的投資,保持著較大的市場佔有率。 TekniPlex位於摩德納的新工廠新增了具有中等阻隔性的PCR薄膜生產線,而Faller Packaging正在德國擴建其折疊式紙盒的生產空間,以滿足對宣傳單的需求。該地區的循環經濟指令正在推動符合藍色回收箱計畫的單一材料吸塑包裝的試點實施。東歐的合約包裝公司正在幫助中小型創新企業獲得歐盟「合格人員」認證,以降低其成本。
According to Mordor Intelligence, pharmaceutical blister packaging market size in 2026 is estimated at USD 24.97 billion, growing from 2025 value of USD 23.31 billion with 2031 projections showing USD 35.17 billion, growing at 7.10% CAGR over 2026-2031.

This report is Segmented by Material (Plastic, Paper and Paperboard, and Aluminum Foil), Technology (Cold Form, Heat-Seal / Heat-Shrink, and Thermoforming), Application (Tablets, Capsules, and More), End-User (Branded / Generic Pharma Manufacturers, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
Regulators see unit-dose formats as an effective way to lower dosing errors, so proposed FDA rules would require over-the-counter orally disintegrating tablets and films to ship only in single-unit packaging. Hospital and retail pharmacists confirm that visual dose cues reduce skipped administrations among seniors. Payers also welcome lower readmission risk, which anchors reimbursement incentives. Contract packers respond by adding multi-product blister lines that let one card hold an entire daily regimen. The effect is quickest in North America, but Europe follows as e-prescription platforms integrate adherence data.
The EU Packaging and Packaging Waste Regulation mandates that all healthcare packs placed on the market after 2030 must be designed for recycling. Suppliers such as TekniPlex now commercialize mid-barrier blister films containing 30% post-consumer resin without sacrificing moisture protection. Borealis' Bornewables grades, produced from renewable feedstock, give origin-controlled polymer options to manufacturers seeking carbon-footprint cuts. Japanese converters add closed-loop systems that collect foil scrap and re-smelt it into pellets, cutting CO2 emissions nearly 20% versus virgin routes.
Aluminum foil is the classic blister barrier but faces price spikes linked to geopolitical tariffs and Chinese export policy shifts. Europe's foil mills reported almost 724 thousand tonnes of nine-month output in 2024, yet supply still tightened after energy-price shocks. Resin makers also pass higher naphtha costs into PVC and PET grades. Brand owners diversify sourcing toward Southeast Asia and Latin America and test polypropylene-based laminates that cut foil gauge without hurting barrier performance.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
supported by mature PVC-PVDC supply chains and proven thermoforming behavior. The pharmaceutical blister packaging market size for plastics aligns with high-volume generic production that values low forming temperatures and predictable seal integrity. Yet paper-based structures are gaining momentum because brand owners want curbside recyclability and lower Scope 3 emissions. Paperboard laminates coated with thin polymer or aluminum layers now approach nine-month shelf-life performance, expanding their use beyond vitamins into prescription gastroenterology drugs.
Demand for aluminum-plastic cold-form foil remains solid because deep-draw cavities shield moisture-sensitive compounds. However, foil gauges are trending lower as converters add nanolayer coatings that deliver equal barrier with less metal. Cold-seal cards from Ecobliss illustrate how pressure-activated adhesive eliminates heat while cutting energy consumption in pack rooms. TekniPlex's 30% PCR blister films demonstrate the direction of resin circularity and keep clarity that pharmacists prefer for visual inspection.
Thermoforming owned 72.45% of the pharmaceutical blister packaging market share in 2025 because it offers high line speeds and clear cavities that support visual confirmation. Form-fill-seal lines routinely cross 600 packs per minute, matching blockbuster tablet volumes. Even so, moisture-sensitive APIs push manufacturers toward cold-forming where aluminum foil delivers near-zero water vapor transmission rates. The pharmaceutical blister packaging market size for cold-form lines grows as specialty generics and orphan-drug volumes climb, despite higher material costs.
Cold-form equipment vendors now integrate servo-driven indexers that improve foil usage, trimming scrap by up to 15%. Aptar CSP Technologies expanded its Active Blister production into Europe to meet regional demand for built-in desiccant channels that prevent hydrolysis without extra sachets. Continuous-manufacturing advocates link powder-to-pack trains where tablets exit compression, pass through weight checks, and reach blister sealing within minutes, minimizing hold-time validation.
Asia-Pacific led with 33.97% of global revenue in 2025 and shows a 8.87% CAGR through 2031. Governments in India, China, and Singapore offer tax credits for automated packaging lines, while local CDMOs win supply contracts for Europe's generics. Japanese suppliers spotlight transparent barrier films and AI inspection at Interphex Tokyo, revealing how digital tools shrink defect rates. Regional harmonization with PIC/S GMP accelerates cross-border distribution, so multinationals can validate a single pack across several ASEAN markets.
North America ranks second due to high-value biologic pipelines and the early rollout of smart adherence packs. The United States also benefits from reshoring moves that shorten supply chains and hedge geopolitical risk. Aluminum tariff reinstatements push converters to secure domestic foil rolling capacity or switch to polymer-based lidding, limiting exposure to import price swings. Canadian facilities integrate renewable electricity, enabling carbon-neutral pack claims that resonate with public payers. Europe maintains significant share thanks to strict quality norms and investment in sustainable materials. TekniPlex's new Modena plant adds mid-barrier PCR film, while Faller Packaging expands folding-carton space in Germany to handle leaflet demand. The region's circular-economy directives drive trials of mono-material blisters that qualify for blue-bin collection schemes. Eastern European contract packers provide cost relief for small and mid-sized innovators seeking EU Qualified Person release.